1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
FY26 DoD Multiple Sclerosis Research Program (MSRP) Early Investigator Research Award (EIRA) is sponsored by Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA). This federal grant supports early-career investigators in conducting multiple sclerosis (MS)-focused research projects under the guidance of mentors.
The award aims to foster the development and independence of the next generation of MS researchers.
Get alerted about grants like this
Get emailed when new opportunities from “Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - DoW Multiple Sclerosis Early Investigator Research Award DoW Multiple Sclerosis Early Investigator Research Award Agency: Defense Health Agency Contracting Activity - DHACA Assistance Listings: 12. 420 -- Military Medical Research and Development Last Updated: May 13, 2026 View version history on Grants.
gov Summary: The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Early Investigator Research Award (EIRA) supports Multiple Sclerosis-focused research opportunities for individuals in the early stages of their careers, under the guidance of one or more designated Mentors. All applications must address at least one of the FY26 MSRP EIRA focus areas.
Distinctive Features: This opportunity allows for early-stage investigators to develop a research project, investigate a problem or question in MS research, and further their intellectual development as an MS researcher of the future. All application components for the EIRA are expected to be written by the Principal Investigator (PI), with appropriate direction from the Mentor(s).
Grantor contact information File name Description Last updated HT942526MSRPEIRA_GG. pdf FY26 MSRP EIRA Program Announcement Link to additional information Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Science technology and other research and development Your account requires additional identity verification.
According to the current listing, eligibility includes: Individuals who possess a doctoral degree (or equivalent) and are in the early stages of their careers (postdoctoral fellows are eligible; faculty members and other non-postdoctoral positions are not eligible). Confirm the full requirements in the official notice before applying.
The current listing shows up to $300,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was August 13, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
FY26 DoD Multiple Sclerosis Research Program (MSRP) Early Investigator Research Award (EIRA) is funded by Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
IDNR's OSLAD program closes at 5:00 p.m. on August 31, 2026, with $37.5 million available, a $1,125,000 ceiling for land acquisition and $600,000 for development. The standard deal is 50/50. The deal that matters for small towns is the full-funding provision for economically distressed communities — and the thing that disqualifies applicants is not the project, it is GATA prequalification.
Read articleAfter SBIR reauthorization, the U.S. Army released five new small-business topics under Army FUZE — Ka-Band metamaterial radar, a Li-ion 6T battery open topic, in-transit-visibility blockchain, modular UAS payloads, and the xTech|Phantum prize competition. Awards run from $150K to $300K per Phase I. But the bigger story is the Army's shift from funding parts to funding whole systems. Here is what each topic funds and how to compete.
Read articleDARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read article